Study to Evaluate the Efficacy and Safety of CKD-352

• Status: Completed
• Trial end date: 2021-05-07
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the efficacy and safety of CKD-352 in patients with dry eye disease

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chong Kun Dang Pharmaceutical

Criteria

Inclusion Criteria:

1. More than the age of 19 years old

2. Subjects with dry eye symptoms for at least 3 month

3. Subjects who sign on an informed consent form willingly

Exclusion Criteria:

1. Subjects who have clinically significant ocular surface diseases, abnormal corneal susceptibility and abnormal epiphora

2. Subjects who have clinically significant medical history of ocular disability

3. Subjects who have malignant tumor within 5 years

4. Subjects with known hypersensitivity to investigational product

5. Women who are nursing, pregnant or planning pregnancy during the study

6. Subjects who have received any other investigational product

7. Impossible subjects who participate in clinical trial by investigator's decision